Full title: Phase 1 trial of Dendritic Cell Vaccination and Temozolomide for Recurrent Glioblastoma Multiform. Cancer type: Glioblastoma Status: Closed (14 recruited from target of 17) Brief description:   The development of drug resistance is a major cause for the failure of chemotherapy in the treatment of cancer patients. We wish to explore the possibility … Continue reading GBM